FundedIQ
Biotechnology

Sonendo: Funding, Investors & Team (Sep 2026)

Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.

www.sonendo.com LinkedIn Laguna Hills, United States 101-250 employees
Total raised
$63.0M
Rounds
1
Latest
Post-IPO Equity
Sep 2022

Sonendo has raised $63.0M across 1 funding round on record, the most recent a Post-IPO Equity of $63.0M announced in Sep 2022.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Sonendo Company Profile and Key Stats

Total funding raised
$63.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Post-IPO Equity
$63.0M in Sep 2022
Employees
101-250
reported band
Headquarters
Laguna Hills, United States

Latest funding round on record: Sep 2022.

Sonendo Funding Rounds

Date
Round
Amount
Post-IPO Equity
$63.0M

Sonendo Founders and Leadership Team

Name
Role
Contact
Bjarne Bergheim
CEO

No contact details are on record for this team yet.

Sonendo Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round

Sonendo's latest round of $63.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Sonendo in Biotechnology and Laguna Hills

Companies Similar to Sonendo

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Sonendo Funding FAQs

What does Sonendo do?

Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.

How much funding has Sonendo raised?

Sonendo has raised $63.0M across 1 round on record. The most recent is a Post-IPO Equity of $63.0M announced in Sep 2022.

When did Sonendo last raise funding?

Sonendo's most recent funding round on record is a Post-IPO Equity of $63.0M, announced in Sep 2022.

Who is the CEO of Sonendo?

Bjarne Bergheim is listed as CEO at Sonendo.

Where is Sonendo headquartered?

Sonendo is based in Laguna Hills, California, United States.

How many employees does Sonendo have?

Sonendo is in the 101-250 employee band.

How does Sonendo's funding compare to other Biotechnology startups?

Sonendo's latest round of $63.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.

About FundedIQ's Sonendo Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sonendo is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.